81 FR 34348 - Clinical Trial Design Considerations for Malaria Drug Development; Notice of Public Workshop; Correction

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration

Federal Register Volume 81, Issue 104 (May 31, 2016)

The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of Tuesday, May 10, 2016 (81 FR 28876). The document announced a public workshop entitled ``Clinical Trial Design Considerations for Malaria Drug Development.'' The document was published with the incorrect title and incorrect Internet address in the Transcripts section. This document corrects those errors.

[Federal Register Volume 81, Number 104 (Tuesday, May 31, 2016)]
[Notices]
[Pages 34348-34349]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-12654]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2016-N-0001]


Clinical Trial Design Considerations for Malaria Drug 
Development; Notice of Public Workshop; Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is correcting a notice 
that appeared in the Federal Register of Tuesday, May 10, 2016 (81 FR 
28876). The document announced a public workshop entitled ``Clinical 
Trial Design Considerations for Malaria Drug Development.'' The 
document was

[[Page 34349]]

published with the incorrect title and incorrect Internet address in 
the Transcripts section. This document corrects those errors.

FOR FURTHER INFORMATION CONTACT: Lori Benner and/or Jessica Barnes, 
Center for Drug Evaluation and Research, Food and Drug Administration, 
10903 New Hampshire Ave., Bldg. 22, Rm. 6221, Silver Spring, MD 20993-
0002, 301-796-1300.

SUPPLEMENTARY INFORMATION: In FR Doc. 2016-10913, appearing on page 
28876 in the Federal Register of Tuesday, May 10, 2016, the following 
corrections are made:
    1. On page 28876, in the first column, the title is corrected to 
read ``Clinical Trial Design Considerations for Malaria Drug 
Development.''
    2. On page 28876, in the second column, the Transcripts section is 
corrected to read ``Please be advised that as soon as a transcript is 
available, it will be accessible at http://www.regulations.gov. It may 
be viewed at the Division of Dockets Management (HFA-305), Food and 
Drug Administration, 5630 Fishers Lane, Rm.1061, Rockville, MD. A 
transcript will also be available in either hard copy or on CD-ROM, 
after submission of a Freedom of Information request. Written requests 
are to be sent to Division of Freedom of Information (HFI-35), Office 
of Management Programs, Food and Drug Administration, 5600 Fishers 
Lane, Rm. 6-30, Rockville, MD 20857. Transcripts will also be available 
on the Internet at http://www.fda.gov/Drugs/NewsEvents/ucm490084.htm 
approximately 45 days after the workshop.
    If you need special accommodations because of a disability, please 
contact Jessica Barnes or Lori Benner (see Contact Person) at least 7 
days in advance.''

    Dated: May 24, 2016.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2016-12654 Filed 5-27-16; 8:45 am]
 BILLING CODE 4164-01-P